Shanmuga Hospital Limited, headquartered in Salem, Tamil Nadu, is a multispecialty healthcare provider with a foundation dating back to 1981. Evolving from a sole proprietorship to a partnership, and later into a public limited entity by June 2024, the hospital has steadily grown in scope and reputation. Key milestones include the establishment of the Salem Cancer Institute in 1996, the region's first oncology-focused hospital, and the creation of the Shanmuga Medical Research Foundation Trust (SMRFT) to support holistic medical services and education. The company's most recent expansion came through the acquisition of the partnership firm M/s. Shanmuga Hospital in December 2023, further consolidating its operations under Shanmuga Hospital Limited.
The hospital operates a 151-bed facility and is accredited by the National Accreditation Board for Hospitals & Healthcare Providers (NABH) and the National Accreditation Board for Testing & Calibration Laboratories (NABL). Known for its state-of-the-art facilities, Shanmuga Hospital offers a range of specialized medical services, including oncology, critical care, cardiology, neonatology, general surgery, emergency care, and diagnostics. Its infrastructure includes advanced imaging technologies such as MRI, CT scans, X-rays, and modular operation theatres, enabling comprehensive healthcare solutions for patients from Salem and surrounding regions.
Now planning an Initial Public Offering (IPO), Shanmuga Hospital Limited aims to raise ₹20.61 crore through a fresh issue of 38,18,000 equity shares. This marks its foray into leveraging equity capital to support future growth and expansion. With a strong track record in medical excellence and a focus on quality care, the hospital is strategically positioned to address increasing healthcare demands in both urban and rural areas.
